Viewing nowCombinationPimaduo Tablet 60/2.5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 202300120 · Approved 2023.01.06 · Insurance code 647805430
Treatment of essential hypertension not controlled with fimasartan monotherapy
This medication is used when blood pressure is not adequately controlled with Pimasartan alone in patients with essential hypertension. It effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose of fimasartan. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients aged 70 years or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with the 30 mg fimasartan dose of this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. However, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine in pediatric and adolescent patients aged 18 years or younger have not been established.
This medication can cause serious harm to the fetus and newborn, especially when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to any of the components of this medication, certain liver or kidney conditions, biliary obstruction, severe aortic stenosis, etc., should not take this medication. Patients with reduced blood volume or decreased sodium levels, those with impaired kidney function, renal artery hypertension patients, and elderly individuals should use this medication with special caution. Side effects such as dizziness, headache, facial edema, urinary disturbances, insomnia, and flushing may occur, and in severe cases, symptoms such as worsening of kidney function or hypotension may appear, so if any unusual symptoms arise, consult a physician immediately. During treatment, hypotension and electrolyte imbalance may occur, especially when taking diuretics, so blood pressure should be closely monitored. This medication can increase serum potassium levels, so patients at risk of hyperkalemia should have regular blood tests. Interactions may occur when taken with other antihypertensive drugs or certain medications, so inform your healthcare provider about any other medications being taken. Pregnant or breastfeeding women should not take this medication, and they should consult a doctor to find a safe alternative if necessary. The safety and efficacy in children and adolescents under 18 years of age have not been established, so its use is not recommended. In case of overdose, hypotension, heart palpitations, and in severe situations, shock may occur, requiring immediate medical attention. Store this medication out of reach of children and do not transfer it to another container as it helps maintain the quality. Dizziness or drowsiness may occur during use, so caution is advised when driving or operating hazardous machinery.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a dark container that does not allow light to enter. It is best to keep it at room temperature between 1 to 30 degrees Celsius.
Yellow, rounded square film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.